SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000902664-23-004214
Filing Date
2023-08-03
Accepted
2023-08-03 16:30:10
Documents
1
Group Members
CALIGAN PARTNERS LPDAVID JOHNSON

Document Format Files

Seq Description Document Type Size
1 ALIMERA SCIENCES, INC. p23-2144sc13da.htm SC 13D/A 50505
  Complete submission text file 0000902664-23-004214.txt   52079
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Subject) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85452 | Film No.: 231140560
SIC: 2834 Pharmaceutical Preparations

Mailing Address 515 MADISON AVENUE 8TH FLOOR NEW YORK NY 10022
Business Address 515 MADISON AVENUE 8TH FLOOR NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

IRS No.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A